Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system

Infection and Immunity

Volumn 83, Issue 1, 2015, Pages 417-429

  Pustelny, Christian ^a,d   Komor, Uliana ^a   Pawar, Vinay ^a   Lorenz, Anne ^a,d   Bielecka, Agata ^a,d   Moter, Annette ^b   Gocht, Benjamin ^b   Eckweiler, Denitsa ^a,d   Müsken, Mathias ^a,d   Grothe, Claudia ^c   Lünsdorf, Heinrich ^a   Weiss, Siegfried ^a   Häussler, Susanne ^a,d  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOFILM; CANCER TISSUE; CELL COUNT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HOST; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; TUMOR MODEL; VEILLONELLA PARVULA; ANIMAL; BACTERIAL LOAD; BAGG ALBINO MOUSE; COMPLICATION; DISEASE MODEL; MICROBIOLOGY; NEOPLASM; ORGANISMAL INTERACTION; PATHOGENICITY; PSEUDOMONAS INFECTION; VEILLONELLA;

ANIMALS; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; MICE, INBRED BALB C; MICROBIAL INTERACTIONS; NEOPLASMS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VEILLONELLA;

EID: 84919470003     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02234-14     Document Type: Article

References (57)

1. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, Curtis JL, Erb-Downward J, Lynch SV, Sethi S, Toews GB, Young VB, Wolfgang MC, Huffnagle GB, Martinez FJ. 2012. Significance of the microbiome in obstructive lung disease. Thorax 67:456-463. http://dx.doi.org/10.1136/thoraxjnl-2011-201183.
2. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA. 2013. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 8:e62917. http://dx.doi.org/10.1371/journal.pone.0062917.
3. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. 2008. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Resp Crit Care Med 177:995-1001. http://dx.doi.org/10.1164/rccm.200708-1151OC.
4. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317-325. http://dx.doi.org/10.1172/JCI200213870.
5. Döring G, Gulbins E. 2009. Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 11:208-216. http://dx.doi.org/10.1111/j.1462-5822.2008.01271.x.
6. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194-222. http://dx.doi.org/10.1128/CMR.15.2.194-222.2002.
7. Jones AM. 2011. Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals? Thorax 66:558-559. http://dx.doi.org/10.1136/thx.2010.157875.
8. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ, Bruce KD. 2006. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 44:2601-2604. http://dx.doi.org/10.1128/JCM.02282-05.
9. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. 2010. The human oral microbiome. J Bacteriol 192:5002-5017. http://dx.doi.org/10.1128/JB.00542-10.
10. Valm AM, Mark Welch JL, Rieken CW, Hasegawa Y, Sogin ML, Oldenbourg R, Dewhirst FE, Borisy GG. 2011. Systems-level analysis of microbial community organization through combinatorial labeling and spectral imaging. Proc Natl Acad Sci U S A 108:4152-4157. http://dx.doi.org/10.1073/pnas.1101134108.
11. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. 2004. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42:5176-5183. http://dx.doi.org/10.1128/JCM.42.11.5176-5183.2004.
12. Rogers GB, Skelton S, Serisier DJ, van der Gast CJ, Bruce KD. 2010. Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol 48: 78-86. http://dx.doi.org/10.1128/JCM.01324-09.
13. Arif N, Sheehy EC, Do T, Beighton D. 2008. Diversity of Veillonella spp. from sound and carious sites in children. J Dent Res 87:278-282. http://dx.doi.org/10.1177/154405910808700308.
14. Hughes CV, Kolenbrander PE, Andersen RN, Moore LV. 1988. Coaggregation properties of human oral Veillonella spp.: relationship to colonization site and oral ecology. Appl Environ Microbiol 54:1957-1963.
15. Bhatti MA, Frank MO. 2000. Veillonella parvula meningitis: case report and review of Veillonella infections. Clin Infect Dis 31:839-840. http://dx.doi.org/10.1086/314046.
16. Aendekerk S, Diggle SP, Song Z, Hoiby N, Cornelis P, Williams P, Camara M. 2005. The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 151:1113-1125. http://dx.doi.org/10.1099/mic.0.27631-0.
17. Marriott D, Stark D, Harkness J. 2007. Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy? J Clin Microbiol 45:672-674. http://dx.doi.org/10.1128/JCM.01633-06.
18. Bongaerts GP, Schreurs BW, Lunel FV, Lemmens JA, Pruszczynski M, Merkx MA. 2004. Was isolation of Veillonella from spinal osteomyelitis possible due to poor tissue perfusion? Med Hypotheses 63:659-661. http://dx.doi.org/10.1016/j.mehy.2004.02.052.
19. Singh N, Yu VL. 1992. Osteomyelitis due to Veillonella parvula: case report and review. Clin Infect Dis 14:361-363. http://dx.doi.org/10.1093/clinids/14.1.361.
20. Marchandin H, Jean-Pierre H, Carriere C, Canovas F, Darbas H, Jumas-Bilak E. 2001. Prosthetic joint infection due to Veillonella dispar. Eur J Clin Microbiol Infect Dis 20:340-342. http://dx.doi.org/10.1007/PL00011273.
21. Shah A, Panjabi C, Nair V, Chaudhry R, Thukral SS. 2008. Veillonella as a cause of chronic anaerobic pneumonitis. Int J Infect Dis 12:e115-e117. http://dx.doi.org/10.1016/j.ijid.2008.03.018.
22. Arrosagaray PM, Salas C, Morales M, Correas M, Barros JM, Cordon ML. 1987. Bilateral abscessed orchiepididymitis associated with sepsis caused by Veillonella parvula and Clostridium perfringens: case report and review of the literature. J Clin Microbiol 25:1579-1580.
23. Boo TW, Cryan B, O'Donnell A, Fahy G. 2005. Prosthetic valve endocarditis caused by Veillonella parvula. J Infect 50:81-83. http://dx.doi.org/10.1016/j.jinf.2003.11.008.
24. Fisher RG, Denison MR. 1996. Veillonella parvula bacteremia without an underlying source. J Clin Microbiol 34:3235-3236.
25. Liu JW, Wu JJ, Wang LR, Teng LJ, Huang TC. 1998. Two fatal cases of Veillonella bacteremia. Eur J Clin Microbiol Infect Dis 17:62-64. http://dx.doi.org/10.1007/BF01584370.
26. Strach M, Siedlar M, Kowalczyk D, Zembala M, Grodzicki T. 2006. Sepsis caused by Veillonella parvula infection in a 17-year-old patient with X-linked agammaglobulinemia (Bruton's disease). J Clin Microbiol 44: 2655-2656. http://dx.doi.org/10.1128/JCM.00467-06.
27. Brook I. 1996. Veillonella infections in children. J Clin Microbiol 34: 1283-1285.
28. Tan PT, Chang LY, Huang YC, Chiu CH, Wang CR, Lin TY. 2001. Deep neck infections in children. J Microbiol Immunol Infect 34:287-292. http://dx.doi.org/10.1016/S1684-1182(10)60007-2.
29. Ulrich M, Beer I, Braitmaier P, Dierkes M, Kummer F, Krismer B, Schumacher U, Grapler-Mainka U, Riethmuller J, Jensen PO, Bjarnsholt T, Hoiby N, Bellon G, Doring G. 2010. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis. Thorax 65:978-984. http://dx.doi.org/10.1136/thx.2010.137745.
30. Duan K, Dammel C, Stein J, Rabin H, Surette MG. 2003. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50:1477-1491. http://dx.doi.org/10.1046/j.1365-2958.2003.03803.x.
31. Komor U, Bielecki P, Loessner H, Rohde M, Wolf K, Westphal K, Weiss S, Haussler S. 2012. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors-a novel model system. Microbes Infect 14:951-958. http://dx.doi.org/10.1016/j.micinf.2012.04.002.
32. Pawar V, Crull K, Komor U, Kasnitz N, Frahm M, Kocijancic D, Westphal K, Leschner S, Wolf K, Loessner H, Rohde M, Haussler S, Weiss S. 2014. Murine solid tumours as a novel model to study bacterial biofilm formation in vivo. J Intern Med 276:130-139. http://dx.doi.org/10.1111/joim.12258.
33. Bielecki P, Komor U, Bielecka A, Musken M, Puchalka J, Pletz MW, Ballmann M, Martins dos Santos VA, Weiss S, Haussler S. 2013. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol 15:570-587. http://dx.doi.org/10.1111/1462-2920.12024.
34. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103:2833-2838. http://dx.doi.org/10.1073/pnas.0511100103.
35. Dötsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V, Scharfe M, Geffers R, Haussler S. 2012. The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS One 7:e31092. http://dx.doi.org/10.1371/journal.pone.0031092.
36. Bundesanzeiger Verlag. 18 May 2006. German animal welfare act (Tierschutzgesetz) TierSchG BGBI S. 1206. Bundesanzeiger Verlag, Bonn, Germany. (In German.) www.bgbl.de/banzxaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl106s1206.pdf.
37. European Commission. 18 December 1986. European Commission directive 86/609/EEC, OJ L 358, p 1-28. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:31986L0609.
38. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, DC. http://www.nap.edu/openbook.php?record_id=5140&page=R1.
39. Lunter G, Goodson M. 2011. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res 21:936-939. http://dx.doi.org/10.1101/gr.111120.110.
40. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11:R106. http://dx.doi.org/10.1186/gb-2010-11-10-r106.
41. Müsken M, Di Fiore S, Romling U, Haussler S. 2010. A 96-well-platebased optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing. Nat Protoc 5:1460-1469. http://dx.doi.org/10.1038/nprot.2010.110.
42. Mueller LN, de Brouwer JF, Almeida JS, Stal LJ, Xavier JB. 2006. Analysis of a marine phototrophic biofilm by confocal laser scanning microscopy using the new image quantification software PHLIP. BMC Ecol 6:1. http://dx.doi.org/10.1186/1472-6785-6-1.
43. Mallmann C, Siemoneit S, Schmiedel D, Petrich A, Gescher DM, Halle E, Musci M, Hetzer R, Gobel UB, Moter A. 2010. Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect 16:767-773. http://dx.doi.org/10.1111/j.1469-0691.2009.02936.x.
44. Moter A, Leist G, Rudolph R, Schrank K, Choi BK, Wagner M, Gobel UB. 1998. Fluorescence in situ hybridization shows spatial distribution of as yet uncultured treponemes in biopsies from digital dermatitis lesions. Microbiology 144(Pt 9):2459-2467. http://dx.doi.org/10.1099/00221287-144-9-2459.
45. Braun-Howland EB, Vescio PA, Nierzwicki-Bauer SA. 1993. Use of a simplified cell blot technique and 16S rRNA-directed probes for identification of common environmental isolates. Appl Environ Microbiol 59: 3219-3224.
46. Sunde PT, Olsen I, Gobel UB, Theegarten D, Winter S, Debelian GJ, Tronstad L, Moter A. 2003. Fluorescence in situ hybridization (FISH) for direct visualization of bacteria in periapical lesions of asymptomatic rootfilled teeth. Microbiology 149:1095-1102. http://dx.doi.org/10.1099/mic.0.26077-0.
47. Wallner G, Amann R, Beisker W. 1993. Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry 14:136-143. http://dx.doi.org/10.1002/cyto.990140205.
48. Spurr AR. 1969. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 26:31-43. http://dx.doi.org/10.1016/S0022-5320(69)90033-1.
49. Lünsdorf H, Strompl C, Osborn AM, Bennasar A, Moore ER, Abraham WR, Timmis KN. 2001. Approach to analyze interactions of microorganisms, hydrophobic substrates, and soil colloids leading to formation of composite biofilms, and to study initial events in microbiogeological processes. Methods Enzymol 336:317-331. http://dx.doi.org/10.1016/S0076-6879(01)36598-9.
50. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. 2008. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68:2952-2960. http://dx.doi.org/10.1158/0008-5472.CAN-07-2984.
51. Leschner S, Weiss S. 2010. Salmonella-allies in the fight against cancer. J Mol Med (Berl) 88:763-773. http://dx.doi.org/10.1007/s00109-010-0636-z.
52. Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, McGrath SJ, Muhlebach MS, Boucher RC, Cardwell C, Doering G, Elborn JS, Wolfgang MC. 2011. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 66:579-584. http://dx.doi.org/10.1136/thx.2010.137281.
53. Worlitzsch D, Rintelen C, Bohm K, Wollschlager B, Merkel N, Borneff-Lipp M, Doring G. 2009. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 15:454-460. http://dx.doi.org/10.1111/j.1469-0691.2008.02659.x.
54. Kara D, Luppens SB, van Marle J, Ozok R, ten Cate JM. 2007. Microstructural differences between single-species and dual-species biofilms of Streptococcus mutans and Veillonella parvula, before and after exposure to chlorhexidine. FEMS Microbiol Lett 271:90-97. http://dx.doi.org/10.1111/j.1574-6968.2007.00701.x.
55. Luppens SB, Kara D, Bandounas L, Jonker MJ, Wittink FR, Bruning O, Breit TM, Ten Cate JM, Crielaard W. 2008. Effect of Veillonella parvula on the antimicrobial resistance and gene expression of Streptococcus mutans grown in a dual-species biofilm. Oral Microbiol Immunol 23:183-189. http://dx.doi.org/10.1111/j.1399-302X.2007.00409.x.
56. El-Sharif A, Elkhatib WF, Ashour HM. 2012. Nosocomial infections in leukemic and solid-tumor cancer patients: distribution, outcome and microbial spectrum of anaerobes. Future Microbiol 7:1423-1429. http://dx.doi.org/10.2217/fmb.12.125.
57. Rybojad P, Los R, Sawicki M, Tabarkiewicz J, Malm A. 2011. Anaerobic bacteria colonizing the lower airways in lung cancer patients. Folia Histochem Cytobiol 49:263-266. http://dx.doi.org/10.5603/FHC.2011.0036.